Hypothesis
We propose that sleep-dependent glymphatic flux actively clears corticotropin-releasing factor (CRF) and associated inflammatory peptides from the amygdala extracellular space. When this nocturnal clearance is impaired—due to aging, sleep fragmentation, or glymphatic dysfunction—CRF accumulates, sustains basolateral amygdala (BLA) hyperexcitability via enhanced CRF‑R1 signaling, and blocks fear extinction independent of memory consolidation (see [1][2]).
Mechanistic Basis
During wakefulness, CRF released from central amygdala (CeA) neurons diffuses into the BLA parenchyma, where it binds CRF‑R1 on glutamatergic principal cells, increasing intracellular calcium and promoting a hyperexcitable state. Concurrently, inflammatory mediators such as IL‑1β and TNF‑α are co‑released, amplifying neuronal excitability through NF‑κB–dependent up‑regulation of NMDA receptor subunits. The glymphatic system, driven by arterial pulsatility and aquaporin‑4 (AQP4)‑mediated convective flow, preferentially clears soluble peptides and cytokines from the interstitial fluid during NREM sleep. Evidence shows that AQP4 polarization declines with age, reducing convective clearance. If CRF and inflammatory peptides are not efficiently removed, their extracellular concentration builds up, leading to persistent CRF‑R1 activation, sustained ERK phosphorylation, and a shift in the excitation/inhibition balance toward excitation. This molecular milieu impairs the synaptic plasticity mechanisms underlying extinction learning, such as long‑term depression (LTD) at BLA‑





























